Literature DB >> 21149591

Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells.

Jianchun Xiao1, Lorraine Jones-Brando, C Conover Talbot, Robert H Yolken.   

Abstract

Strain type is one of the key factors suspected to play a role in determining the outcome of Toxoplasma infection. In this study, we examined the transcriptional profile of human neuroepithelioma cells in response to representative strains of Toxoplasma by using microarray analysis to characterize the strain-specific host cell response. The study of neural cells is of interest in light of the ability of Toxoplasma to infect the brain and to establish persistent infection within the central nervous system. We found that the extents of the expression changes varied considerably among the three strains. Neuroepithelial cells infected with Toxoplasma type I exhibited the highest level of differential gene expression, whereas type II-infected cells had a substantially smaller number of genes which were differentially expressed. Cells infected with type III exhibited intermediate effects on gene expression. The three strains also differed in the individual genes and gene pathways which were altered following cellular infection. For example, gene ontology (GO) analysis indicated that type I infection largely affects genes related to the central nervous system, while type III infection largely alters genes which affect nucleotide metabolism; type II infection does not alter the expression of a clearly defined set of genes. Moreover, Ingenuity Pathways Analysis (IPA) suggests that the three lineages differ in the ability to manipulate their host; e.g., they employ different strategies to avoid, deflect, or subvert host defense mechanisms. These observed differences may explain some of the variation in the neurobiological effects of different strains of Toxoplasma on infected individuals.

Entities:  

Mesh:

Year:  2010        PMID: 21149591      PMCID: PMC3067490          DOI: 10.1128/IAI.00947-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Systematic determination of genetic network architecture.

Authors:  S Tavazoie; J D Hughes; M J Campbell; R J Cho; G M Church
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

2.  Functional changes of the sciatic nerve in mice chronically infected with Trypanosoma cruzi.

Authors:  A S Losavio; R E Sica; O P Sanz; G Mirkin; S M González Cappa; S Muchnik
Journal:  Medicina (B Aires)       Date:  1993       Impact factor: 0.653

3.  Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients.

Authors:  Y Suzuki; S Y Wong; F C Grumet; J Fessel; J G Montoya; A R Zolopa; A Portmore; F Schumacher-Perdreau; M Schrappe; S Köppen; B Ruf; B W Brown; J S Remington
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

4.  Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis.

Authors:  D K Howe; S Honoré; F Derouin; L D Sibley
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Toxoplasmosis: maternal and pediatric findings in 23,000 pregnancies.

Authors:  J L Sever; J H Ellenberg; A C Ley; D L Madden; D A Fuccillo; N R Tzan; D M Edmonds
Journal:  Pediatrics       Date:  1988-08       Impact factor: 7.124

6.  Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.

Authors:  R Q Hintzen; S M Lens; K Lammers; H Kuiper; M P Beckmann; R A van Lier
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

7.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease.

Authors:  D K Howe; L D Sibley
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

Review 8.  Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.

Authors:  C Bole-Feysot; V Goffin; M Edery; N Binart; P A Kelly
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

9.  Testes and brain gene expression in precocious male and adult maturing Atlantic salmon (Salmo salar).

Authors:  Aoife Guiry; Denis Flynn; Sophie Hubert; Allan M O'Keeffe; Olivier LeProvost; Samantha L White; Patrick F Forde; Pamela Davoren; Benoit Houeix; Terry J Smith; Deirdre Cotter; Noel P Wilkins; Michael T Cairns
Journal:  BMC Genomics       Date:  2010-03-30       Impact factor: 3.969

10.  Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis.

Authors:  N Benedetto; A Folgore; M Galdiero; R Meli; R Di Carlo
Journal:  Pathol Biol (Paris)       Date:  1995-05
View more
  27 in total

1.  Differential gene expression in mice infected with distinct Toxoplasma strains.

Authors:  Rachel D Hill; Julia S Gouffon; Arnold M Saxton; Chunlei Su
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 2.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

3.  Gastrointestinal inflammation and associated immune activation in schizophrenia.

Authors:  Emily G Severance; Armin Alaedini; Shuojia Yang; Meredith Halling; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2012-03-24       Impact factor: 4.939

4.  Toxoplasma gondii and neuropsychiatric diseases: strain hypothesis.

Authors:  Amir Abdoli
Journal:  Neurol Sci       Date:  2012-12-07       Impact factor: 3.307

5.  Toxoplasma genotyping in congenital toxoplasmosis in Upper Egypt: evidence of type I strain.

Authors:  Hanan E M Eldeek; Alzahraa Abdel Raouf Ahmad; Mohamed Ahmed El-Mokhtar; Abdel Rahman M M Abdel Kader; Ahmad M Mandour; Mahmoud Elhady M Mounib
Journal:  Parasitol Res       Date:  2017-07-01       Impact factor: 2.289

6.  Cerebral complement C1q activation in chronic Toxoplasma infection.

Authors:  Jianchun Xiao; Ye Li; Kristin L Gressitt; Helen He; Geetha Kannan; Tracey L Schultz; Nadezhda Svezhova; Vern B Carruthers; Mikhail V Pletnikov; Robert H Yolken; Emily G Severance
Journal:  Brain Behav Immun       Date:  2016-04-22       Impact factor: 7.217

7.  Persistent Toxoplasma Infection of the Brain Induced Neurodegeneration Associated with Activation of Complement and Microglia.

Authors:  Ye Li; Emily G Severance; Raphael P Viscidi; Robert H Yolken; Jianchun Xiao
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

8.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

9.  MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway.

Authors:  J Xiao; Y Li; E Prandovszky; S S Karuppagounder; C C Talbot; V L Dawson; T M Dawson; R H Yolken
Journal:  Neuroscience       Date:  2014-03-18       Impact factor: 3.590

Review 10.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.